Stock Market & Financial Investment News

Zimmer unlikely to be strongly impacted by AAOS guidance, says Wells FargoWells Fargo reports that the American Academy of Orthopedic Surgeons, or AAOS, will recommend against the use of hyaluronic acid, or HA, for osteoarthritis of the knee, while Zimmer is in the process of launching its single injection HA, Gel-one in the U.S. The firm thinks the guidance could have a temporary negative impact on HA, but it doesn't expect the impact on Zimmer to be dramatic. The firm doesn't expect doctors who have already had success with HA to stop using it, and it maintains an Outperform rating on Zimmer.